The APERLURI brand, founded in 2009 (United States), from 5 sister brands and 2214 competing brands. APERLURI is owned by PTC Therapeutics, listed on the stock exchange of New York APERLURI belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
PTC Therapeutics
(APERLURI)
over 5 years*
USD 22.23